Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -1.20% | 136.26 | 0.0% | $876.09m | |
| AMGN | Amgen, Inc. | 0.19% | 243.87 | 1.5% | $800.58m | |
| GILD | Gilead Sciences, Inc. | -0.21% | 62.24 | 1.0% | $521.82m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 3.02% | 254.17 | 1.9% | $450.04m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.47% | 655.01 | 2.6% | $404.30m | |
| ILMN | Illumina, Inc. | 0.08% | 233.74 | 3.3% | $282.61m | |
| NVAX | Novavax, Inc. | -7.50% | 48.00 | 75.7% | $279.78m | |
| BIIB | Biogen, Inc. | -0.37% | 198.38 | 1.8% | $245.45m | |
| BNTX | BioNTech SE | -4.81% | 151.20 | 0.0% | $211.21m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 13.90% | 2.13 | 0.7% | $148.89m | |
| EXAS | EXACT Sciences Corp. | -3.33% | 50.55 | 17.7% | $132.03m | |
| NKTX | Nkarta, Inc. | -1.14% | 13.86 | 0.0% | $111.92m | |
| TECH | Bio-Techne Corp. | -1.53% | 362.13 | 4.5% | $98.39m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.53% | 77.32 | 4.2% | $97.55m | |
| TXG | 10X Genomics, Inc. | -2.79% | 46.30 | 0.0% | $89.30m |
Company Profile
Prothena Corp. Plc is a clinical-stage neuroscience company. It focuses on the discovery and development of novel therapies to change the course of devastating diseases. The firm’s clinical pipeline includes both wholly-owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.